Trademarkia Logo

Canada

C$
DEYAMLI
FORMALIZED

on 16 Apr 2025

Last Applicant/ Owned by

Kymab Limited

The Bennet Building (B930),Babraham Research CampusCambridge CB22 3AT

GB

Serial Number

2392880 filed on 11th Dec 2024

DEYAMLI

Trademark usage description

pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of immune-mediated diseases and disorders, n Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of immune-mediated diseases and disorders, namely Atopic Dermatitis, Asthma, Systemic Sclerosis, Hidradenitis Suppurativa, Alopecia Areata, and Celiac Disease; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, damaged skin and tissues; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of respiratory diseases and disorders.


Classification kind code

12

Mark Details


Serial Number

2392880

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 17th Apr 2025
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 16th Apr 2025
Created
Submitted for opposition 31
on 16th Apr 2025
Formalized
Submitted for opposition 228
on 11th Dec 2024
International Registration
Submitted for opposition 30
on 11th Dec 2024
Filed